Prostate Cancer articles, blogs, webinars, videos, fact sheets, resources, etc.
Ask Dr. Domchek: Men and BRCA Mutations
Basser Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.
Ask Dr. Domchek: BRCA and Individualized Risk
Basser Executive Director Susan Domchek, MD, discusses hereditary cancer risk for BRCA mutation carriers and ways in which that might impact individuals differently.
2016 Basser Center Symposium Interview with Kara Maxwell
Dr. Kara Maxwell, MD, PhD is on the Basser Center's clinical staff. She's a physician-scientist with an interest in breast cancer genetics. Her major area of research interest is in the mechanisms of cancer development in individuals at high risk of breast cancer.
About BRCA with Dr. Susan Domchek
The Basser Center for BRCA's Executive Director, Susan Domchel, MD, sheds some light on BRCA mutations and hereditary cancer.
Introduction to Genetic Testing: Prostate Cancer
Germline genetic testing for cancer susceptibility is currently recommended for advanced prostate cancer patients due to potential implications for targeted therapies and risk assessment of family members. This video was created in an effort to share existing resources and increase genetic testing rates in those with advanced prostate cancer patients.
Ask Dr. Domchek: Enhancing PARP Inhibitors
As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.
Prostate Cancer Screening with a BRCA Mutation
Kara Maxwell, MD, PhD, a physician scientist with the Basser Center and University of Pennsylvania, discusses hereditary prostate cancer and recent scientific advancements.
Ask Dr. Domchek: Men and BRCA Mutations
As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.
Ask Dr. Domchek: Recent Treatment Options for BRCA-Related Cancers
In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.